5 Stocks Advancing The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 119 points (0.7%) at 16,493 as of Wednesday, Jan. 15, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,941 issues advancing vs. 990 declining with 158 unchanged.

The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.5%. Top gainers within the industry include Globus Medical ( GMED), up 4.6%, Edwards Life ( EW), up 3.4% and Express Scripts ( ESRX), up 0.8%. On the negative front, top decliners within the industry include HCA Holdings ( HCA), down 1.0%, Grifols ( GRFS), down 1.0% and Smith & Nephew ( SNN), down 0.7%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. NuVasive ( NUVA) is one of the companies pushing the Health Services industry higher today. As of noon trading, NuVasive is up $2.62 (7.8%) to $36.40 on heavy volume. Thus far, 1.1 million shares of NuVasive exchanged hands as compared to its average daily volume of 460,500 shares. The stock has ranged in price between $36.35-$37.25 after having opened the day at $36.62 as compared to the previous trading day's close of $33.78.

NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedurally integrated solutions for the spine. The company's products focus on applications for spine fusion surgery. NuVasive has a market cap of $1.5 billion and is part of the health care sector. Shares are up 4.5% year-to-date as of the close of trading on Tuesday. Currently there are 7 analysts who rate NuVasive a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates NuVasive as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full NuVasive Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

4. As of noon trading, Cooper Companies ( COO) is up $2.72 (2.1%) to $129.10 on average volume. Thus far, 198,861 shares of Cooper Companies exchanged hands as compared to its average daily volume of 427,400 shares. The stock has ranged in price between $126.20-$129.17 after having opened the day at $126.20 as compared to the previous trading day's close of $126.38.

The Cooper Companies, Inc. operates as a medical device company worldwide. Cooper Companies has a market cap of $6.0 billion and is part of the health care sector. The company has a P/E ratio of 20.8, above the S&P 500 P/E ratio of 17.7. Shares are up 2.0% year-to-date as of the close of trading on Tuesday. Currently there are 7 analysts who rate Cooper Companies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Cooper Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cooper Companies Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

3. As of noon trading, Align Technology ( ALGN) is up $1.06 (1.8%) to $61.46 on average volume. Thus far, 650,658 shares of Align Technology exchanged hands as compared to its average daily volume of 897,700 shares. The stock has ranged in price between $60.59-$62.43 after having opened the day at $60.64 as compared to the previous trading day's close of $60.40.

Align Technology, Inc. operates as a medical device company primarily in the United States and internationally. Align Technology has a market cap of $4.7 billion and is part of the health care sector. The company has a P/E ratio of 154.4, above the S&P 500 P/E ratio of 17.7. Shares are up 5.7% year-to-date as of the close of trading on Tuesday. Currently there are 5 analysts who rate Align Technology a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Align Technology as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Align Technology Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Boston Scientific ( BSX) is up $0.20 (1.5%) to $13.38 on average volume. Thus far, 8.3 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 11.7 million shares. The stock has ranged in price between $13.17-$13.50 after having opened the day at $13.19 as compared to the previous trading day's close of $13.18.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $17.3 billion and is part of the health care sector. Shares are up 9.7% year-to-date as of the close of trading on Tuesday. Currently there are 5 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Boston Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is up $0.48 (0.7%) to $74.50 on average volume. Thus far, 2.7 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.6 million shares. The stock has ranged in price between $73.99-$74.64 after having opened the day at $73.99 as compared to the previous trading day's close of $74.02.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $74.4 billion and is part of the health care sector. The company has a P/E ratio of 14.0, below the S&P 500 P/E ratio of 17.7. Shares are down 1.7% year-to-date as of the close of trading on Tuesday. Currently there are 14 analysts who rate UnitedHealth Group a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full UnitedHealth Group Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers